Timothy Baumgartner
Partner, Corporate & Financial Services
Tim Baumgartner is a partner in the Corporate & Financial Services Department and a member of Willkie’s Insurance Transactional and Regulatory Practice Group.
Tim has extensive experience advising on a wide range of corporate transactions over the course of 20 years, including international and domestic M&A (including competitive auction processes on the buy and sell side), joint ventures and long-term strategic partnerships, intra-group restructurings and general corporate advisory work.
In addition to general corporate transactions, Tim has a particular focus in the insurance sector, advising on the full spectrum of corporate insurance transactions, which in addition to the above includes transactions within the Lloyd’s market (M&A, reinsurance and fundraising), portfolio transfers and complex reinsurance transactions for both life and non-life businesses.
Tim is ranked in Chambers UK (2026) for Non-Contentious Insurance and is recognised by The Legal 500 UK (2026) as a Key Lawyer for Insurance: Corporate and Regulatory. He has been described by clients as “shining in corporate insurance transactions” and was previously noted as having “deep technical expertise in the M&A area and general corporate law. He is a great lawyer to work with and quickly absorbs the client’s needs and specific requirements. Tim is a solutions-oriented lawyer.”
Experience
Prior to joining Willkie in 2022, Tim was a partner in the Corporate Department at another international law firm. He also previously worked for seven years in the London office of a New York-based international law firm.
Tim has advised on the following selected significant matters.*
Recent corporate insurance transactions advising:
-
AIG on its acquisition of the renewal rights for a majority of Everest Group Ltd.’s retail insurance portfolios worldwide, representing approximately $2 billion of premium in aggregate
-
AIG on the sale and reacquisition of its Greek intermediary operations
- Aon on a number of M&A transactions globally, including by way of MBOs, and including recent transactions in Pakistan and Guam
- ARAG, a premium provider of legal expense insurance, on the acquisition of the Irish and UK branch business of DAS Insurance
- Ariel Re and its key shareholders on further investment from National Indemnity Company, a subsidiary of Berkshire Hathaway
- Athora on the sale of its non-life business in Belgium to Baloise
- Best Doctors on the sale of its international medical insurance business to a subsidiary of the Primary Group
- Compre on a number of its legacy insurance transactions with Generali, QBE, Partner Re, Baloise, Hannover and AG Insurance
- Compre’s management team on the sale of Compre from CBPE to Cinven
- Cover-More on the acquisition of Blue Insurance (Ireland) from its founder shareholders
- CVS and Aetna International on the preferred partnership deal involving Aetna International’s International Private Medical Insurance business outside of the Americas, Thailand and India
- Fosun (Chinese based conglomerate) on a number of confidential, high-value acquisitions of insurance groups
-
Generali on sale of the renewal rights to its UK Employee Benefits business to Unum and its long-term strategic partnership with the company
-
MetLife Inc. and American Life Insurance Company (ALICO) on the sale of part of their UK branch business to Admin Re
- Pelican Ventures on the acquisition of Ariel Re from Argo Group International Holdings and the investment as part of the deal from J.C. Flowers
- Premia on the acquisition of Armour Re Limited and Reliance National Insurance Company Europe
- Saudi Reinsurance Company on its strategic partnership with AdA
- Saudi Reinsurance Company on the sale its 49.9% stake in Probitas to Aviva plc
- Scottish Widows on a longevity reinsurance transaction with Swiss Re
- Tawa on the acquisition of PXRE Reinsurance Company, Pro Insurance, Island Capital and KX Re (and sale of KX Re)
- Zurich on the acquisition of intermediaries Oak Underwriting and Tennyson Insurance (both UK)
- Zurich on the sale to RiverStone of the non-life insurance business (in run off) of Eagle Star Insurance Company
- Zurich on a number of other confidential transactions globally including those involving the transfer of renewal rights, significant transitional services arrangements and bancassurance arrangements
Other recent general corporate transactions advising:
- Aviva Investors on the sale of its Central European Property Fund to Partners Group
- Hain Celestial on acquisition of Ella’s Kitchen from its founder shareholders and also the acquisition and subsequent sale of its Tilda rice business to Ebro
- Discovery on its joint venture in Poland with Polsat and the launch of an video on demand platform
- Dynamo Software on the sale by its founder shareholders to Francisco Partners
- Leidos on its acquisition of the security detection and automation business of L3 Harris
- Skanska on the sale of its interest in the A1 motorway joint venture to DIF Infrastructure and Swiss Life Funds
- Sulzer on the acquisition of P.C. Cox’s UK and US operations
- Sulzer Chemtech on its investment into Worn Again Technologies and acquisition of PC Cox
Recent global reorganizations advising:
- GE Capital on the restructuring of its European equipment services business prior to its sale to HNA
- Kimberly-Clark on restructuring of its healthcare business prior to its spin-off as Halyard Health (now known as Avanos Medical)
- Lockheed Martin on the pre-sale restructuring of its IS&GS business prior to its sale to Leidos
- Merlin Entertainments on a number of internal strategic reorganizations
*Tim advised on these matters prior to joining Willkie.
Credentials
Education
Oxford Institute of Legal Practice, L.P.C., 2005 Oxford University, Masters of Law, 2004 Allegheny College, B.A., 1999